Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 409

1.

The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.

Velkov T, Ong C, Baker MA, Kim H, Li J, Nation RL, Huang JX, Cooper MA, Rockman S.

Mol Immunol. 2013 Dec;56(4):705-19. doi: 10.1016/j.molimm.2013.07.010. Epub 2013 Aug 7. Review.

PMID:
23933511
2.

Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.

Rockman S, Camuglia S, Vandenberg K, Ong C, Baker MA, Nation RL, Li J, Velkov T.

Mol Immunol. 2013 Apr;53(4):435-42. doi: 10.1016/j.molimm.2012.10.001. Epub 2012 Nov 3.

PMID:
23127859
3.

H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.

Khurana S, Wu J, Verma N, Verma S, Raghunandan R, Manischewitz J, King LR, Kpamegan E, Pincus S, Smith G, Glenn G, Golding H.

J Virol. 2011 Nov;85(21):10945-54. doi: 10.1128/JVI.05406-11. Epub 2011 Aug 24.

4.

Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.

Ohkura T, Kikuchi Y, Kono N, Itamura S, Komase K, Momose F, Morikawa Y.

Biochem Biophys Res Commun. 2012 Feb 3;418(1):38-43. doi: 10.1016/j.bbrc.2011.12.108. Epub 2011 Dec 27.

PMID:
22226969
5.

Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.

Prabakaran M, He F, Meng T, Madhan S, Yunrui T, Jia Q, Kwang J.

J Virol. 2010 Nov;84(22):11822-30. doi: 10.1128/JVI.00891-10. Epub 2010 Sep 15.

6.

A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin.

Zhu X, Guo YH, Jiang T, Wang YD, Chan KH, Li XF, Yu W, McBride R, Paulson JC, Yuen KY, Qin CF, Che XY, Wilson IA.

J Virol. 2013 Dec;87(23):12619-35. doi: 10.1128/JVI.01577-13. Epub 2013 Sep 18.

7.

Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.

Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Krylov PS, Webster RG.

J Virol. 2007 Dec;81(23):12911-7. Epub 2007 Sep 19.

8.

A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.

Hu H, Voss J, Zhang G, Buchy P, Zuo T, Wang L, Wang F, Zhou F, Wang G, Tsai C, Calder L, Gamblin SJ, Zhang L, Deubel V, Zhou B, Skehel JJ, Zhou P.

J Virol. 2012 Mar;86(6):2978-89. doi: 10.1128/JVI.06665-11. Epub 2012 Jan 11.

9.

Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.

Hervé PL, Lorin V, Jouvion G, Da Costa B, Escriou N.

Virology. 2015 Dec;486:134-45. doi: 10.1016/j.virol.2015.08.033. Epub 2015 Oct 1.

10.

Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.

Yamashita A, Kawashita N, Kubota-Koketsu R, Inoue Y, Watanabe Y, Ibrahim MS, Ideno S, Yunoki M, Okuno Y, Takagi T, Yasunaga T, Ikuta K.

Biochem Biophys Res Commun. 2010 Mar 19;393(4):614-8. doi: 10.1016/j.bbrc.2010.02.031. Epub 2010 Feb 10.

PMID:
20152806
11.

Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.

Khurana S, Chearwae W, Castellino F, Manischewitz J, King LR, Honorkiewicz A, Rock MT, Edwards KM, Del Giudice G, Rappuoli R, Golding H.

Sci Transl Med. 2010 Jan 20;2(15):15ra5. doi: 10.1126/scitranslmed.3000624.

12.

The antigenic drift molecular basis of the H5N1 influenza viruses in a novel branch of clade 2.3.4.

Zhong L, Zhao Q, Zhao K, Wang X, Zhao G, Li Q, Gu M, Peng D, Liu X.

Vet Microbiol. 2014 Jun 25;171(1-2):23-30. doi: 10.1016/j.vetmic.2014.02.033. Epub 2014 Mar 2.

PMID:
24745625
13.

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J.

PLoS One. 2008;3(12):e3942. doi: 10.1371/journal.pone.0003942. Epub 2008 Dec 16.

14.

A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.

Tan Y, Ng Q, Jia Q, Kwang J, He F.

J Virol. 2015 Apr;89(7):3712-22. doi: 10.1128/JVI.03014-14. Epub 2015 Jan 21.

15.

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.

Schmeisser F, Friedman R, Besho J, Lugovtsev V, Soto J, Wang W, Weiss C, Williams O, Xie H, Ye Z, Weir JP.

Influenza Other Respir Viruses. 2013 May;7(3):480-90. doi: 10.1111/irv.12029. Epub 2012 Nov 5.

16.

Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.

Jadhao SJ, Lee CW, Sylte M, Suarez DL.

Vaccine. 2009 Oct 19;27(44):6247-60. doi: 10.1016/j.vaccine.2009.07.110. Epub 2009 Aug 15.

PMID:
19686695
17.

Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.

He F, Prabakaran M, Rajesh Kumar S, Tan Y, Kwang J.

Antiviral Res. 2014 May;105:143-51. doi: 10.1016/j.antiviral.2014.03.002. Epub 2014 Mar 15.

PMID:
24637255
18.

The epitope and neutralization mechanism of AVFluIgG01, a broad-reactive human monoclonal antibody against H5N1 influenza virus.

Cao Z, Meng J, Li X, Wu R, Huang Y, He Y.

PLoS One. 2012;7(5):e38126. doi: 10.1371/journal.pone.0038126. Epub 2012 May 25.

19.

Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface display.

Li J, Wang Y, Liang Y, Ni B, Wan Y, Liao Z, Chan KH, Yuen KY, Fu X, Shang X, Wang S, Yi D, Guo B, Di B, Wang M, Che X, Wu Y.

Eur J Immunol. 2009 Dec;39(12):3498-510. doi: 10.1002/eji.200939532. Erratum in: Eur J Immunol. 2010 Mar;40(3):911. Chan, Kwok-hong [corrected to Chan, Kwok-hung].

20.

Genetic drift evolution under vaccination pressure among H5N1 Egyptian isolates.

Abdel-Moneim AS, Afifi MA, El-Kady MF.

Virol J. 2011 Jun 8;8:283. doi: 10.1186/1743-422X-8-283.

Supplemental Content

Support Center